A Study of the Safety and Activity of the MEK Inhibitor Given Together With the AKT Inhibitor to Patients With Multiple Myeloma or Solid Tumor Cancers
Clinical trial NCT01476137 · COMPLETED
Trial details
- NCT number
- NCT01476137
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-26
- Primary completion
- 2013-03-12
- Enrollment
- 335
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.